BioSyent Inc.
BIOYF
$7.69
$0.182.40%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -31.90% | 46.51% | -11.97% | 23.02% | -39.16% |
| Total Depreciation and Amortization | 317.60% | -4.50% | 4.84% | 351.88% | -135.63% |
| Total Amortization of Deferred Charges | -85.71% | 8.89% | -4.26% | -96.12% | 2,023.81% |
| Total Other Non-Cash Items | 461.90% | 2.00% | 63.35% | 42.01% | -773.99% |
| Change in Net Operating Assets | -89.24% | 236.40% | -336.00% | -39.14% | -4,284.88% |
| Cash from Operations | -61.36% | 538.44% | -255.73% | 42.87% | -72.37% |
| Capital Expenditure | -223.61% | -20.00% | -160.87% | 92.60% | -217.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.85% | -170.38% | 2,360.31% | 133.13% | 10.50% |
| Cash from Investing | 117.08% | -170.60% | 2,384.28% | 131.26% | 7.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.30% | -0.88% | -1.33% | -1.81% | -1.38% |
| Issuance of Common Stock | 223.11% | 32.11% | -- | -- | -- |
| Repurchase of Common Stock | -16,515.79% | 93.83% | 76.56% | -91.89% | -35.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.16% | -0.37% | 2.01% | -11.95% | 1.53% |
| Other Financing Activities | 4.11% | 2.67% | 3.85% | 4.88% | 3.53% |
| Cash from Financing | -637.69% | 39.06% | 58.36% | -69.38% | -11.54% |
| Foreign Exchange rate Adjustments | 217.99% | -9,550.00% | 100.00% | 100.09% | -305.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.27% | -79.19% | 606.51% | 44.70% | -551.44% |